tiprankstipranks
Arovella Therapeutics Limited (AU:ALA)
ASX:ALA

Arovella Therapeutics Limited (ALA) Income Statement

4 Followers

Arovella Therapeutics Limited Income Statement

Last quarter (Q4 2022), Arovella Therapeutics Limited's total revenue was AU$―, a decrease of ― from the same quarter last year. In Q4, Arovella Therapeutics Limited's net income was AU$―. See Arovella Therapeutics Limited’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Jun 22Jun 21Jun 20Jun 19Jun 18
Total Revenue
-AU$ 295.81KAU$ 257.35KAU$ 532.69KAU$ 1.22MAU$ 425.86K
Cost of Revenue
-AU$ 207.06KAU$ 222.75KAU$ 200.97KAU$ 199.69KAU$ 185.62K
Gross Profit
-AU$ 88.75KAU$ 34.60KAU$ 331.72KAU$ 1.02MAU$ 240.24K
Operating Expense
-AU$ 7.69MAU$ 4.70MAU$ 5.13MAU$ 3.38MAU$ 6.35M
Operating Income
-AU$ -7.60MAU$ -4.67MAU$ -4.80MAU$ -2.36MAU$ -6.11M
Net Non Operating Interest Income Expense
-AU$ -190.88KAU$ -26.75KAU$ 22.24KAU$ -94.26KAU$ -174.50K
Other Income Expense
-AU$ -833.27KAU$ -354.60KAU$ -5.82MAU$ -6.27MAU$ -497.31K
Pretax Income
-AU$ -8.62MAU$ -5.05MAU$ -10.59MAU$ -8.72MAU$ -6.78M
Tax Provision
-AU$ 0.00AU$ 0.00AU$ -655.88KAU$ -925.00KAU$ -745.00K
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
-AU$ -8.62MAU$ -5.05MAU$ -9.94MAU$ -7.80MAU$ -5.46M
Basic EPS
-AU$ -0.02AU$ -0.02AU$ -0.06AU$ -0.07-
Diluted EPS
-AU$ -0.02AU$ -0.02AU$ -0.06AU$ -0.07-
Basic Average Shares
-AU$ 549.62MAU$ 330.89MAU$ 167.91MAU$ 116.36M-
Diluted Average Shares
-AU$ 549.62MAU$ 330.89MAU$ 167.91MAU$ 116.36M-
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
------
Net Income From Continuing And Discontinued Operation
-AU$ -8.62MAU$ -5.05MAU$ -9.94MAU$ -7.80MAU$ -5.46M
Normalized Income
-AU$ -7.79MAU$ -3.79MAU$ -4.34MAU$ -2.16MAU$ -5.53M
Interest Expense
-AU$ 194.72KAU$ 33.29KAU$ 6.57KAU$ 125.06KAU$ 177.03K
EBIT
-AU$ -8.43MAU$ -5.01MAU$ -10.58MAU$ -8.59MAU$ -6.60M
EBITDA
-AU$ -7.87MAU$ -4.36MAU$ -10.01MAU$ -8.12MAU$ -6.44M
Currency in AUD

Arovella Therapeutics Limited Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis